Download original image
Fig. 1. Comparison of death-censored overall graft survival rate (A) and death-censored graft survival rate after diagnosis of chronic antibody-mediated rejection (CABMR) (B) according to the presence of de novo donor-specific antibody (dnDSA).
Korean J Transplant 2021;35:33~40 https://doi.org/10.4285/kjt.20.0052
© Korean Journal of Transplantation